Anti-PARD3B monoclonal antibody
Pre-made anti-PARD3B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to PARD3B/PARD3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2642-Ab-1/ GM-Tg-hg-IP2642-Ab-2 | Anti-Human PARD3B monoclonal antibody | Human |
GM-Tg-rg-IP2642-Ab-1/ GM-Tg-rg-IP2642-Ab-2 | Anti-Rat PARD3B monoclonal antibody | Rat |
GM-Tg-mg-IP2642-Ab-1/ GM-Tg-mg-IP2642-Ab-2 | Anti-Mouse PARD3B monoclonal antibody | Mouse |
GM-Tg-cynog-IP2642-Ab-1/ GM-Tg-cynog-IP2642-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PARD3B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2642-Ab-1/ GM-Tg-felg-IP2642-Ab-2 | Anti-Feline PARD3B monoclonal antibody | Feline |
GM-Tg-cang-IP2642-Ab-1/ GM-Tg-cang-IP2642-Ab-2 | Anti-Canine PARD3B monoclonal antibody | Canine |
GM-Tg-bovg-IP2642-Ab-1/ GM-Tg-bovg-IP2642-Ab-2 | Anti-Bovine PARD3B monoclonal antibody | Bovine |
GM-Tg-equg-IP2642-Ab-1/ GM-Tg-equg-IP2642-Ab-2 | Anti-Equine PARD3B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2642-Ab-1/ GM-Tg-hg-IP2642-Ab-2; GM-Tg-rg-IP2642-Ab-1/ GM-Tg-rg-IP2642-Ab-2; GM-Tg-mg-IP2642-Ab-1/ GM-Tg-mg-IP2642-Ab-2; GM-Tg-cynog-IP2642-Ab-1/ GM-Tg-cynog-IP2642-Ab-2; GM-Tg-felg-IP2642-Ab-1/ GM-Tg-felg-IP2642-Ab-2; GM-Tg-cang-IP2642-Ab-1/ GM-Tg-cang-IP2642-Ab-2; GM-Tg-bovg-IP2642-Ab-1/ GM-Tg-bovg-IP2642-Ab-2; GM-Tg-equg-IP2642-Ab-1/ GM-Tg-equg-IP2642-Ab-2 |
Products Name | Anti-PARD3B monoclonal antibody |
Format | mab |
Target Name | PARD3B |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-PARD3B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2642-Ag-1 | Recombinant multi-species PAR3L/ PARD3B/ ALS2CR19 protein |
Target information
Target ID | GM-IP2642 |
Target Name | PARD3B |
Gene ID | 117583,72823,301455,707941,478879,101089538,535378,100068099 |
Gene Symbol and Synonyms | 1810008K04Rik,2010002N16Rik,2810455B10Rik,ALS2CR19,PAR3B,PAR3beta,PAR3L,PARD3B |
Uniprot Accession | Q8TEW8 |
Uniprot Entry Name | PAR3L_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000116117 |
Target Classification | N/A |
The target: PARD3B, gene name: PARD3B, also named as ALS2CR19, PAR3B, PAR3L, PAR3beta. Predicted to enable phosphatidylinositol binding activity. Predicted to be involved in several processes, including establishment of cell polarity; establishment of centrosome localization; and establishment or maintenance of epithelial cell apical/basal polarity. Located in cell junction. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.